Cargando…
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling
Pancreatic ductal adenocarcinoma (PDAC) patients display distinct phenotypes of cachexia development, with either adipose tissue loss preceding skeletal muscle wasting or loss of only adipose tissue. Activin A levels were measured in serum and analyzed in tumor specimens of both a cohort of Stage IV...
Autores principales: | Xu, Pauline C., You, Mikyoung, Yu, Seok-Yeong, Luan, Yi, Eldani, Maya, Caffrey, Thomas C., Grandgenett, Paul M., O’Connell, Kelly A., Shukla, Surendra K., Kattamuri, Chandramohan, Hollingsworth, Michael A., Singh, Pankaj K., Thompson, Thomas B., Chung, Soonkyu, Kim, So-Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803848/ https://www.ncbi.nlm.nih.gov/pubmed/35102236 http://dx.doi.org/10.1038/s41598-022-05660-7 |
Ejemplares similares
-
Pancreatic Ductal Adenocarcinoma Highly Expresses Activin A: Implications in Adipose Tissue and Cancer Cachexia
por: Xu, Pauline, et al.
Publicado: (2021) -
Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma
por: Yu, Seok‐Yeong, et al.
Publicado: (2023) -
Activin A Plays a Critical Role in Adipose Tissue Wasting in the Progression of Cancer Cachexia
por: Luan, Yi, et al.
Publicado: (2021) -
THU507 Tumor Activin A Mediates Cachexia Primarily Through White Adipose Tissue Hydrolysis In Pancreatic Ductal Adenocarcinoma
por: Yu, Seok-Yeong, et al.
Publicado: (2023) -
Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2019)